Pathways for cross-priming

被引:0
|
作者
Olive Leavy
机构
来源
Nature Reviews Immunology | 2015年 / 15卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
RIPK1 and NF-κB signalling in dying cells are necessary for CD8+T cell cross-priming.
引用
收藏
页码:725 / 725
相关论文
共 50 条
  • [21] Type I interferon as a stimulus for cross-priming
    Le Bon, Agnes
    Tough, David F.
    CYTOKINE & GROWTH FACTOR REVIEWS, 2008, 19 (01) : 33 - 40
  • [22] Isothermal cross-priming amplification implementation study
    Bai, Z.
    Xie, H.
    You, Q.
    Pickerill, S.
    Zhang, Y.
    Li, T.
    Geng, J.
    Hu, L.
    Shan, H.
    Di, B.
    LETTERS IN APPLIED MICROBIOLOGY, 2015, 60 (03) : 205 - 209
  • [23] Cellular protein is the source of cross-priming antigen in vivo
    Shen, LJ
    Rock, KL
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (09) : 3035 - 3040
  • [24] CTL induction by cross-priming is restricted to immunodominant epitopes
    Pavelic, Viktor
    Matter, Matthias S.
    Mumprecht, Sabine
    Breyer, Isabel
    Ochsenbein, Adrian F.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2009, 39 (03) : 704 - 716
  • [25] Transfusion tickles T cells through cross-priming
    Gorham, JD
    BLOOD, 2006, 107 (01) : 6 - 7
  • [26] Activation of regulatory T cells via cross-priming
    Smith, TR
    Maricic, I
    Pedersen, B
    Kumar, V
    FASEB JOURNAL, 2005, 19 (04): : A413 - A413
  • [27] The cross-priming pathway: A portrait of an intricate immune system
    Basta, S.
    Alatery, A.
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2007, 65 (04) : 311 - 319
  • [28] Cross-priming versus direct priming in anti-tumoural immune responses
    Pavelic, V.
    Matter, M.
    Mumprecht, S.
    Ochsenbein, A. F.
    SWISS MEDICAL WEEKLY, 2008, 138 : 38S - 38S
  • [29] Cross-priming versus cross-tolerance:: are two signals enough?
    Blankenstein, T
    Schüler, T
    TRENDS IN IMMUNOLOGY, 2002, 23 (04) : 171 - 173
  • [30] Myeloid differentiation factor 88 is required for cross-priming in vivo
    Palliser, D
    Ploegh, H
    Boes, M
    JOURNAL OF IMMUNOLOGY, 2004, 172 (06): : 3415 - 3421